Grifols Class A/€GRF
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Grifols Class A
Grifols SA, operating under the ticker GRF, is a biopharmaceutical company specialized in the production of plasma-derived medicines. Founded in 1940 and headquartered in Barcelona, Spain, Grifols is engaged in the diagnosis, prevention, and treatment of a variety of diseases, with a strong focus on immunology, hematology, and intensive care sectors. The company operates globally, leveraging advanced technologies and rigorous quality processes to provide essential medical products.
Ticker
€GRF
Sector
Health
Primary listing
BME
Employees
23,833
Headquarters
Website
Grifols Class A Metrics
BasicAdvanced
€7.9B
28.17
€0.45
1.01
-
Price and volume
Market cap
€7.9B
Beta
1.01
52-week high
€13.80
52-week low
€7.32
Average daily volume
894K
Financial strength
Current ratio
2.636
Quick ratio
0.806
Long term debt to equity
119.998
Total debt to equity
126.869
Interest coverage (TTM)
2.73%
Profitability
EBITDA (TTM)
1,652.516
Gross margin (TTM)
39.64%
Net profit margin (TTM)
3.99%
Operating margin (TTM)
20.00%
Effective tax rate (TTM)
37.62%
Revenue per employee (TTM)
€310,000
Management effectiveness
Return on assets (TTM)
4.43%
Return on equity (TTM)
4.99%
Valuation
Price to earnings (TTM)
28.171
Price to revenue (TTM)
1.123
Price to book
1.51
Price to tangible book (TTM)
-1.45
Price to free cash flow (TTM)
12.018
Free cash flow yield (TTM)
8.32%
Free cash flow per share (TTM)
1.059
Growth
Revenue change (TTM)
9.32%
Earnings per share change (TTM)
132.60%
3-year revenue growth (CAGR)
12.66%
10-year revenue growth (CAGR)
7.40%
3-year earnings per share growth (CAGR)
67.45%
10-year earnings per share growth (CAGR)
-4.84%
What the Analysts think about Grifols Class A
Analyst ratings (Buy, Hold, Sell) for Grifols Class A stock.
Grifols Class A Financial Performance
Revenues and expenses
Grifols Class A Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Grifols Class A stock?
Grifols Class A (GRF) has a market cap of €7.9B as of August 12, 2025.
What is the P/E ratio for Grifols Class A stock?
The price to earnings (P/E) ratio for Grifols Class A (GRF) stock is 28.17 as of August 12, 2025.
Does Grifols Class A stock pay dividends?
No, Grifols Class A (GRF) stock does not pay dividends to its shareholders as of August 12, 2025.
When is the next Grifols Class A dividend payment date?
Grifols Class A (GRF) stock does not pay dividends to its shareholders.
What is the beta indicator for Grifols Class A?
Grifols Class A (GRF) has a beta rating of 1.01. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.